Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized studySilvia Fargion, Gemino Fiorelli, Oliviero Riggio et al.|The American Journal of Gastroenterology|2002Cited by 80
The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective studyFrancesco Salerno, Mauro Borzio, Claudia Pedicino et al.|Liver International|2016Cited by 76
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyMauro Borzio, Fabio Fornari, E. Dionigi et al.|Hepatology|2017Cited by 49
755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICSPietro Lampertico, M. Colombo, R. Soffredini et al.|Journal of Hepatology|2013Cited by 24
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort studyMauro Borzio, Rodolfo Sacco, E. Dionigi et al.|Liver International|2017Cited by 23